Publications by authors named "E F M Posthuma"

Claim this Profile
I
Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study.
Dina Nienke Lokhorst, Yolba Smit, Bart J F Van den Bemt, Rosella P M G Hermens, Marten R Nijziel, Eduardus F M Posthuma

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia.
Kathelijn Verdeyen, Tom Reuvekamp, Walter J F M Van der Velden, Bas J Wouters, Peter A Von dem Borne, Eduardus F M Posthuma

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time data in cancer registries: Validation of an automated data extraction system.
Sylvie A M Langhout, Sjoerd J F Hermans, Anna J T Smit, Elizabeth Berkx, Sophie A Kurk, Eduardus F M Posthuma

iScience· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicians' experiences, perspectives, barriers, and facilitators of integrating palliative care into hematological malignancy care: a qualitative interview study.
Beaudine M van den Berg, Carly S Heipon, Corine Korf, Anna van Rhenen, Eduardus F M Posthuma

Support Care Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis.
Yolba Smit, Pien Scheuter, Myrthe P M Lange, Jeroen J W M Janssen, Eduardus F M Posthuma

Support Care Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis